🕒 Last update: loading…

Stock Rh RH

Rh — Investlytic score 0/5 on the five criteria.

-
-
0/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 0/5 criteria met.

  • ❌ Price trend failed
  • ⚠️ Mixed growth
  • ❌ Debt failed
  • ❌ P/E failed
  • ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2018 → 2019: 78.18%

Price change 2019 → 2020: 109.61%

Price change 2020 → 2021: 19.76%

Price change 2021 → 2022: -50.15%

Price change 2022 → 2023: 9.09%

Price change 2023 → 2024: 35.03%

Price change 2024 → 2025: -54.48%

Price change 2025 → 2026: -7.61%

Price change 2026 (year to date): -14.42%

Financial growth

Revenue CAGR (8 years): 4.63%

Earnings CAGR (8 years): -2.65%

Growth status: positive trend (>1%/yr) in revenue OR earnings, but not both.

Debt

Debt-to-equity ratio: 65.50

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 28.68

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 22.08% from the high over 6 months.

Excessive correction (> 20.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Rh34.965.50+10.5 %🔒
Trigano S.A.9.70.18+11.7 %★ 5/5
Advance Auto Parts, Inc.13.92.38+2.5 %–
Lagardere S.A.12.75.77+0.8 %–
Valeo SE13.51.98+5.3 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by Rh over the latest fiscal years.

Revenue
3.4 bn USD
fiscal year 2025
Net income
125 m USD
fiscal year 2025
Net margin
3.6 %
fiscal year 2025
Average annual growth
+3.8 %
Revenue growth over 5 years
Average annual growth
+5.0 %
Revenue growth over 10 years
Market cap
2.5 bn USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
20202.8 bn272 m9.5 %n/a
20213.8 bn689 m18.3 %+32.0 %
20223.6 bn529 m14.7 %-4.5 %
20233.0 bn128 m4.2 %-15.6 %
20243.2 bn72.4 m2.3 %+5.0 %
20253.4 bn125 m3.6 %+8.1 %

Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Rh over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
fragile accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
1.13
risk zone (below 1.81)
Piotroski Score
6 / 9
4 to 6: average accounts
DCF Value
111.25 USD
DCF close to share price · share price 131.82 USD, gap -15.6 %
Net Debt / EBITDA
7.83 x
high debt
Fiscal year20212022202320242025
Cash and investments2.2 bn1.5 bn124 m30.4 m41.2 m
Total Debt3.4 bn3.7 bn3.7 bn3.9 bn4.0 bn
Net Debt1.3 bn2.2 bn3.6 bn3.9 bn3.9 bn
Equity1.2 bn785 m-297 m-164 m60.6 m
Total assets5.5 bn5.3 bn4.1 bn4.6 bn4.8 bn
Operating cash flow662 m404 m202 m17.1 m452 m
Investments (capex)185 m174 m269 m231 m203 m
Free cash-flow477 m230 m-67.1 m-214 m252 m
Share buybacks01.0 bn1.3 bn12.0 m0
Dividends paid00000

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)22.16 x
Price / book value20.58 x
Return on Equity (ROE)184.9 %
Return on Invested Capital (ROIC)6.0 %
Net margin3.2 %
Debt / equity34.14 x
Current ratio1.12 x
Interest coverage1.57 x
Free cash-flow yield10.0 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.

+

Valuation and competitors

Rh compared with its sector on the same exchange and with its main competitors.

Company P/E
31.2
44.0 % above the sector
Sector median P/E
21.6
consumer cyclical, NYSE
Sector over 10 years
24.7
10-year median, range 16.6 to 35.2

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on . Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering Rh publish: ratings, price targets and earnings forecasts.

Majority rating
buy
37 analysts
Average price target
158.63 USD
from n/a to n/a, 23 targets over 12 months
Gap with the share price
+8.2 %
price 146.66 USD on 30/10/2026

Breakdown of ratings

strong buy 0buy 18hold 17sell 2strong sell 0

Analysts' average target 158.63 USD, DCF value 111.25 USD, share price 146.66 USD.

Average target over the last 3 months: 158.63 USD (8 targets).

Track record against expectations: reported EPS above consensus 4 times over the last 12 releases.

Source: ratings and forecasts published by analysts, collected on 07/11/2026. An analyst rating or target is not a guarantee.

+

Dividends and earnings

Rh: dividend history, last distributions, stock splits and earnings releases.

No known dividend for this company.

Earnings releases

Next release: 10/12/2026. Expected EPS: 0.69.

Factual data: ex-dividend history and earnings calendar, as of 05/11/2026. A past dividend does not guarantee the next one.

+

Who owns the stock

Free float, institutional investors, large funds, executives and elected officials: declared positions in Rh.

Large funds tracked
25
hold the stock as of 2026Q2
Executives (insiders)
0 / 3
0 purchases, 3 sales in 130 days
US elected officials
2
1 purchases, 1 sales in 12 months

Large funds tracked

FundSharesValue (USD)Weight in the fundChangeQuarter
Fidelity2.8 m467 m0.0 %+1.4 %2026Q2
BlackRock2.0 m326 m0.0 %+41.7 %2026Q2
Vanguard Group1.4 m251 m0.0 %-0.7 %2025Q4
State Street1.2 m193 m0.0 %+148.4 %2026Q2
Two Sigma Investments763,447126 m0.1 %+175.9 %2026Q2
Morgan Stanley466,07276.8 m0.0 %-12.6 %2026Q2
Citadel Advisors433,04871.3 m0.0 %+342.4 %2026Q2
Geode Capital Management414,94768.4 m0.0 %+44.4 %2026Q2

Latest insider transactions

DatePersonSideAmount
22/09/2026Demilio Mark Ssale132,000 USD
10/07/2026Demilio Mark Ssale219,842 USD
10/07/2026Demilio Mark Ssale191,984 USD

Elected officials' disclosures

DateOfficialSideAmount
24/09/2026Maria Elvira Salazarsale$1,001 - $15,000
19/03/2026Maria Elvira Salazarpurchase$15,001 - $50,000

Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 08/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
NYSE
IPO: 02/11/2012
ISIN code
US74967X1037
Workforce
5,690
full-time employees
Chief executive
Gary G. Friedman
Next earnings
10/12/2026

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Rh

What is the Rh share price?

Latest recorded price: 130.96 USD on 06/11/2026, for a market cap of 2.5 bn USD.

What is the revenue of Rh?

3.4 bn USD for fiscal year 2025, with net income of 125 m USD (net margin 3.6 %).

When does Rh report its next earnings?

The next release is expected on 10/12/2026. EPS expected by analysts: 0.69.

What do analysts say about Rh?

Out of 37 analysts: 18 buy or strong buy, 17 hold, 2 sell or strong sell. Average price target: 158.63 USD, i.e. +8.2 % from the share price.

What is the P/E ratio of Rh?

Trailing 12-month P/E of 31.2, against 21.6 for the sector median on the same exchange (10-year median: 24.7).

Is Rh stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US74967X1037).

How many employees does Rh have?

5,690 full-time employees according to the latest published profile.

Who runs Rh?

Gary G. Friedman is the company's chief executive.

Which large funds own Rh?

As of 2026Q2, among the large funds tracked: Fidelity, BlackRock, Vanguard Group, State Street, Two Sigma Investments.

07

Similar stocks